Analysts Anticipate Xylem Inc (NYSE:XYL) to Post $0.82 EPS

Equities research analysts expect Xylem Inc (NYSE:XYL) to announce earnings of $0.82 per share for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for Xylem’s earnings. The lowest EPS estimate is $0.80 and the highest is $0.84. Xylem posted earnings of $0.77 per share during the same quarter last year, which would indicate a positive year over year growth rate of 6.5%. The company is scheduled to issue its next quarterly earnings report before the market opens on Thursday, October 31st.

On average, analysts expect that Xylem will report full-year earnings of $3.16 per share for the current fiscal year, with EPS estimates ranging from $3.12 to $3.20. For the next year, analysts forecast that the business will report earnings of $3.63 per share, with EPS estimates ranging from $3.47 to $3.75. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that follow Xylem.

Xylem (NYSE:XYL) last posted its earnings results on Thursday, August 1st. The industrial products company reported $0.79 EPS for the quarter, hitting the consensus estimate of $0.79. Xylem had a net margin of 10.90% and a return on equity of 19.23%. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same period last year, the company earned $0.73 EPS. The firm’s revenue was up 2.1% compared to the same quarter last year.

Several equities research analysts recently commented on XYL shares. Jefferies Financial Group started coverage on shares of Xylem in a research report on Friday, September 20th. They set a “buy” rating and a $90.00 target price on the stock. Credit Suisse Group downgraded shares of Xylem from an “outperform” rating to a “neutral” rating in a research report on Friday, August 2nd. ValuEngine downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Zacks Investment Research upgraded shares of Xylem from a “sell” rating to a “hold” rating and set a $83.00 target price on the stock in a research report on Saturday, September 14th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $80.00.

NYSE:XYL traded up $2.20 during mid-day trading on Thursday, hitting $77.63. 657,702 shares of the company’s stock were exchanged, compared to its average volume of 762,093. The company has a 50 day simple moving average of $76.92 and a 200-day simple moving average of $78.95. The company has a current ratio of 1.47, a quick ratio of 1.08 and a debt-to-equity ratio of 0.71. Xylem has a fifty-two week low of $60.65 and a fifty-two week high of $85.39. The firm has a market capitalization of $13.58 billion, a P/E ratio of 26.95, a PEG ratio of 1.45 and a beta of 1.19.

The company also recently declared a quarterly dividend, which was paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th were issued a dividend of $0.24 per share. The ex-dividend date of this dividend was Wednesday, August 28th. This represents a $0.96 annualized dividend and a yield of 1.24%. Xylem’s payout ratio is 33.33%.

In other Xylem news, SVP Kenneth Napolitano sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $75.90, for a total transaction of $379,500.00. Following the completion of the transaction, the senior vice president now owns 36,228 shares in the company, valued at approximately $2,749,705.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Colin R. Sabol sold 4,099 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $78.37, for a total transaction of $321,238.63. Following the transaction, the senior vice president now owns 33,518 shares of the company’s stock, valued at approximately $2,626,805.66. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 19,099 shares of company stock valued at $1,464,339. Company insiders own 0.85% of the company’s stock.

Large investors have recently added to or reduced their stakes in the company. Meridian Wealth Management LLC bought a new stake in shares of Xylem in the 1st quarter valued at $30,000. FinTrust Capital Advisors LLC increased its stake in shares of Xylem by 1,530.4% in the 2nd quarter. FinTrust Capital Advisors LLC now owns 375 shares of the industrial products company’s stock valued at $31,000 after acquiring an additional 352 shares in the last quarter. Private Ocean LLC bought a new stake in shares of Xylem in the 2nd quarter valued at $33,000. Doyle Wealth Management bought a new stake in shares of Xylem in the 2nd quarter valued at $46,000. Finally, BSW Wealth Partners bought a new stake in shares of Xylem in the 1st quarter valued at $45,000. Institutional investors own 84.49% of the company’s stock.

About Xylem

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Featured Story: What is the Current Ratio?

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.